The group’s principal activity is to provide pharmaceutical and medicial products services. The group provides pain management solutions for patients. The group are also developing novel products that effectively treat chronic and acute pain and minimize side effects commonly associated with other, widely-used pain therapeutics. The group provides treatments for pain, rheumatologists, orthopedists, neurologists, podiatrists and primary care physicians. The group was founded in 2003. The group operates from the United States.
